|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun JH, Luo Q, Liu LL and Song GB: Liver
cancer stem cell markers: Progression and therapeutic implications.
World J Gastroenterol. 22:3547–3557. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shao J, Fan W, Ma B and Wu Y: Breast
cancer stem cells expressing different stem cell markers exhibit
distinct biological characteristics. Mol Med Rep. 14:4991–4998.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen YC, Hsu HS, Chen YW, Tsai TH, How CK,
Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tirino V, Camerlingo R, Franco R, Malanga
D, La Rocca A, Viglietto G, Rocco G and Pirozzi G: The role of
CD133 in the identification and characterisation of
tumour-initiating cells in non-small-cell lung cancer. Eur J
Cardiothorac Surg. 36:446–453. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meng X, Li M, Wang X, Wang Y and Ma D:
Both CD133+ and CD133- subpopulations of A549 and H446 cells
contain cancer-initiating cells. Cancer Sci. 100:1040–1046. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiu X, Wang Z, Li Y, Miao Y, Ren Y and
Luan Y: Characterization of sphere-forming cells with stem-like
properties from the small cell lung cancer cell line H446. Cancer
Lett. 323:161–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hongo K, Tanaka J, Tsuno NH, Kawai K,
Nishikawa T, Shuno Y, Sasaki K, Kaneko M, Hiyoshi M, Sunami E, et
al: CD133(−) cells, derived from a single human colon cancer cell
line, are more resistant to 5-fluorouracil (FU) than CD133(+)
cells, dependent on the β1-integrin signaling. J Surg Res.
175:278–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roudi R, Madjd Z, Ebrahimi M, Samani FS
and Samadikuchaksaraei A: CD44 and CD24 cannot act as cancer stem
cell markers in human lung adenocarcinoma cell line A549. Cell Mol
Biol Lett. 19:23–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu H, Mu J, Xiao J, Wu X, Li M, Liu T and
Liu X: CD24 negative lung cancer cells, possessing partial cancer
stem cell properties, cannot be considered as cancer stem cells. Am
J Cancer Res. 6:51–60. 2015.PubMed/NCBI
|
|
12
|
Huo W, Du M, Pan X, Zhu X and Li Z:
Prognostic value of ALDH1 expression in lung cancer: A
meta-analysis. Int J Clin Exp Med. 8:2045–2051. 2015.PubMed/NCBI
|
|
13
|
Sulpice E, Plouët J, Bergé M, Allanic D,
Tobelem G and Merkulova-Rainon T: Neuropilin-1 and neuropilin-2 act
as coreceptors, potentiating proangiogenic activity. Blood.
111:2036–2045. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ango F: NRP1 and synapse formation.
Oncotarget. 7:81975–81976. 2016.PubMed/NCBI
|
|
15
|
Cimato T, Beers J, Ding S, Ma M, McCoy JP,
Boehm M and Nabel EG: Neuropilin-1 identifies endothelial
precursors in human and murine embryonic stem cells before CD34
expression. Circulation. 119:2170–2178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ball SG, Bayley C, Shuttleworth CA and
Kielty CM: Neuropilin-1 regulates platelet-derived growth factor
receptor signalling in mesenchymal stem cells. Biochem J.
427:29–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hong TM, Chen YL, Wu YY, Yuan A, Chao YC,
Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, et al: Targeting
neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer
Res. 13:4759–4768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
MicroRNA-338 inhibits growth, invasion and metastasis of gastric
cancer by targeting NRP1 expression. PLoS One. 9:e944222014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao Y, Wang L, Nandy D, Zhang Y, Basu A,
Radisky D and Mukhopadhyay D: Neuropilin-1 upholds
dedifferentiation and propagation phenotypes of renal cell
carcinoma cells by activating Akt and sonic hedgehog axes. Cancer
Res. 68:8667–8672. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hamerlik P, Lathia JD, Rasmussen R, Wu Q,
Bartkova J, Lee M, Moudry P, Bartek J Jr, Fischer W, Lukas J, et
al: Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma
stem-like cell viability and tumor growth. J Exp Med. 209:507–520.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barr MP, Gray SG, Gately K, Hams E, Fallon
PG, Davies AM, Richard DJ, Pidgeon GP and O'Byrne KJ: Vascular
endothelial growth factor is an autocrine growth factor, signaling
through neuropilin-1 in non-small cell lung cancer. Mol Cancer.
14:452015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Skirecki T, Hoser G, Kawiak J, Dziedzic D
and Domagała-Kulawik J: Flow cytometric analysis of CD133- and
EpCAM-positive cells in the peripheral blood of patients with lung
cancer. Arch Immunol Ther Exp. 62:67–75. 2014. View Article : Google Scholar
|
|
25
|
Kajstura J, Rota M, Hall SR, Hosoda T,
D'Amario D, Sanada F, Zheng H, Ogórek B, Rondon-Clavo C,
Ferreira-Martins J, et al: Evidence for human lung stem cells. N
Engl J Med. 364:1795–1806. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lamb R, Lisanti MP, Clarke RB and Landberg
G: Co-ordination of cell cycle, migration and stem cell-like
activity in breast cancer. Oncotarget. 5:7833–7842. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miljkovic-Licina M, Hammel P,
Garrido-Urbani S, Lee BP, Meguenani M, Chaabane C, Bochaton-Piallat
ML and Imhof BA: Targeting olfactomedin-like 3 inhibits tumor
growth by impairing angiogenesis and pericyte coverage. Mol Cancer
Ther. 11:2588–2599. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kastrati I, Canestrari E and Frasor J:
PHLDA1 expression is controlled by an estrogen
receptor-NFκB-miR-181 regulatory loop and is essential for
formation of ER+ mammospheres. Oncogene. 34:2309–2316. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brusselmans K, Bono F, Collen D, Herbert
JM, Carmeliet P and Dewerchin M: A novel role for vascular
endothelial growth factor as an autocrine survival factor for
embryonic stem cells during hypoxia. J Biol Chem. 280:3493–3499.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Misra RM, Bajaj MS and Kale VP:
Vasculogenic mimicry of HT1080 tumour cells in vivo: Critical role
of HIF-1α-neuropilin-1 axis. PLoS One. 7:e501532012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oh JE, Kim RH, Shin KH, Park NH and Kang
MK: DeltaNp63α protein triggers epithelial-mesenchymal transition
and confers stem cell properties in normal human keratinocytes. J
Biol Chem. 286:38757–38767. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rock JR, Onaitis MW, Rawlins EL, Lu Y,
Clark CP, Xue Y, Randell SH and Hogan BL: Basal cells as stem cells
of the mouse trachea and human airway epithelium. Proc Natl Acad
Sci USA. 106:pp. 12771–12775. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y, Zhao J, Luo Y, Wang Y, Wei N and
Jiang Y: Isolation and identification of cancer stem-like cells
from side population of human prostate cancer cells. J Huazhong
Univ Sci Technolog Med Sci. 32:697–703. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Leung EL, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boldrup L, Coates PJ, Gu X and Nylander K:
DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in
squamous cell carcinoma of head and neck. J Pathol. 213:384–391.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ruan Y, Li H, Zhang K, Jian F, Tang J and
Song Z: Loss of Yme1L perturbates mitochondrial dynamics. Cell
Death Dis. 4:e8962013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Singh H, Lu R, Bopassa JC, Meredith AL,
Stefani E and Toro L: MitoBKCa is encoded by the Kcnma1 gene, and a
splicing sequence defines its mitochondrial location. Proc Natl
Acad Sci USA. 110:pp. 10836–10841. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matin RN, Chikh A, Chong SL, Mesher D,
Graf M, Sanza' P, Senatore V, Scatolini M, Moretti F, Leigh IM, et
al: p63 is an alternative p53 repressor in melanoma that confers
chemoresistance and a poor prognosis. J Exp Med. 210:581–603. 2013.
View Article : Google Scholar : PubMed/NCBI
|
